Longview Partners Portfolio holdings
Longview Partners is a specialist global equity manager that holds a concentrated portfolio of world stocks, using the same philosophy since it started in 2001. It looks for high-quality businesses that can build value steadily over time, wants a margin of safety on price, and relies on picking individual stocks rather than steering the overall portfolio. Its clients are institutions, and Northill Capital is its majority shareholder.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$536M |
| 2 |
Fidelity National Information Services
FIS
|
+$75.7M |
| 3 |
UnitedHealth
UNH
|
+$75.2M |
| 4 |
L3Harris
LHX
|
+$60.8M |
| 5 |
Sysco
SYY
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Henry Schein
HSIC
|
+$317M |
| 2 |
Zimmer Biomet
ZBH
|
+$276M |
| 3 |
Oracle
ORCL
|
+$39.4M |
| 4 |
Booking.com
BKNG
|
+$17.8M |
| 5 |
Microsoft
MSFT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.89% |
| 2 | Healthcare | 22.83% |
| 3 | Technology | 19.11% |
| 4 | Consumer Staples | 9.33% |
| 5 | Consumer Discretionary | 9.11% |
Similar funds
Longview Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Longview Partners held 27 positions worth $15.3B, up 7.7% from $14.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Longview Partners's Q2 2023 filing shows 2 new, 8 increased, 16 reduced and 1 closed positions. Its largest new stake was Dollar General: 2,710,691 shares worth $460M. The largest sale was Henry Schein, an estimated $317M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.
- Longview Partners's largest Q2 2023 buy was Dollar General: 2,710,691 shares worth $460M.
- Longview Partners added most to UnitedHealth in Q2 2023, an estimated $75.2M increase.
- Longview Partners's biggest Q2 2023 reduction was Henry Schein, cutting an estimated $317M.
- Longview Partners fully exited Zimmer Biomet in Q2 2023, selling an estimated $276M.
- Longview Partners's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2023.
- Longview Partners opened 2 new positions and closed 1 in Q2 2023.
- Longview Partners's portfolio value rose 7.7% quarter-over-quarter to $15.3B.
Based on Longview Partners's 13F filing for Q2 2023, filed 11 Aug 2023.